Abstract
Objective: Vaccination against SARS-CoV-2 has been shown to be effective in preventing infection and severe disease. Massive bleeding and transfusion after vaccination can lead to a decrease in the antibody level. The effect of an additional dose of vaccine after blood transfusion has not been described previously. In this case report, we report the SARS-CoV-2 anti-S IgG trajectory in a male patient who received a third dose of vaccine after a massive postoperative bleed and blood and plasma transfusion.
Case presentation: A 57-year-old male physician had a SARS-CoV-2 anti-S IgG level of 44 AU/mL, measured using the Lumipulse Presto chemiluminescence assay 3 months after receiving 2 doses of the BNT162b2 vaccine. The patient underwent a hemicolectomy for colon cancer, experienced massive postoperative bleeding, and required a transfusion. The patient’s SARS-CoV-2 anti-S IgG level dropped to 9.2 AU/mL. A third dose of BNT162b2 vaccination was administered to reduce the risk of breakthrough infection. Fifteen days after receiving the third vaccine dose, the patient’s SARS-CoV-2 anti-S IgG level increased to 421 AU/mL, likely to reflect protection.
Conclusion: This report suggests that administering an extra dose of vaccine is useful for restoring protective antibody levels in vaccinated patients who experience massive postoperative bleeding.
Keywords: BNT162b2 vaccine; COVID-19; Massive bleeding; Plasma transfusion; SARS-CoV-2 anti-S IgG.
【저자키워드】 COVID-19, BNT162b2 vaccine, Massive bleeding, Plasma transfusion, SARS-CoV-2 anti-S IgG., 【초록키워드】 SARS-CoV-2, Vaccine, vaccination, antibody, risk, Case report, vaccine dose, BNT162b2, male, Patient, bleeding, trajectory, Breakthrough infection, chemiluminescence, Blood, Protective, anti-S IgG, dose, severe disease, Colon cancer, massive, Administered, effective, decrease, shown, described, the patient, required, receiving, postoperative, reduce, dropped, of BNT162b2, postoperative bleeding, preventing infection, the SARS-CoV-2, 【제목키워드】 SARS-CoV-2, Vaccine, Case report, Patient, dose, postoperative, anti-S IgG level, of BNT162b2,